Skip to content

Safety and Performance of Short- and Long-term Baseplates for Attaching the UNEEG Episight Recorder - Part II

Safety and Performance of Short- and Long-term Baseplates for Attaching the UNEEG Episight Recorder - Part II

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06934005
Enrollment
10
Registered
2025-04-18
Start date
2022-08-22
Completion date
2022-10-06
Last updated
2025-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Brief summary

The purpose of this clinical investigation is to test the safety and performance of one short- and one long-term Baseplate constructed with different types of biocompatible adhesives.

Detailed description

This clinical investigation intended to test different biocompatible adhesives over time as part of the UNEEG Episight Baseplate construction for UNEEG™ medical A/S. The two Baseplates reported on in this registration, is a follow-up to an initial testing of four different types of adhesive i.e., four types of Baseplates. This study is Part II of the protocol. Part I is registered: NCT05111847

Interventions

DEVICEBaseplate type A

Type A: Acrylate tested for 35 days behind one ear

DEVICEBaseplate type C

Type C: Hydrocolloid tested for 35 days behind the other ear

Sponsors

UNEEG Medical A/S
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Following a cross-over design in Part I of the study, two of the four initial Baseplates, is tested for longer wear time (35 days) in this Part II of the study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
Yes

Inclusion criteria

* Informed consent obtained, and letter of authority signed before any study related activities * Are at least 18 years of age and have full legal capacity * Healthy skin behind the ear

Exclusion criteria

* Pregnant or breastfeeding * Known allergic responses to the adhesives * Treatment with corticosteroids, either as a cream in the area behind the ear or systemically (tablet or injection) within the last month * Subject is unable or does not have the necessary assistance to properly operate the device system

Design outcomes

Primary

MeasureTime frameDescription
Trans epidermal water loss (TEWL) to measure skin-friendliness35 daysTo evaluate the skin barrier functionality (i.e., skin-friendliness) after repeated use of Baseplates (i.e., adhesives) on the skin behind the ear. High levels of TEWL equates to unhealthy skin = high loss of water that passes from inside a body through the epidermis.High levels of TEWL equates to unhealthy skin = high loss of water that passes from inside a body through the epidermis.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026